What to expect when you take Cefixime and Cipro?

Do you take Cefixime and Cipro? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.



On Mar, 20, 2018

942 reports have been studied.


Females aged 50 to 59 :

544 related reports were analyzed:

Most common symptoms:

Back pain
  • 7.44% for females aged 50 (±5) who take Cipro
Conjunctival abrasion
  • 5.75% for females aged 50 (±5) who take Cefixime
Diarrhea
  • 6.56% for females aged 50 (±5) who take Cipro
Dizziness
  • 6.9% for females aged 50 (±5) who take Cefixime
Drug hypersensitivity
  • 5.03% for females aged 50 (±5) who take Cipro
Dyspnea
  • 7.66% for females aged 50 (±5) who take Cipro
Exostosis
  • 5.75% for females aged 50 (±5) who take Cefixime
Fall
  • 5.03% for females aged 50 (±5) who take Cipro
Fatigue
  • 9.63% for females aged 50 (±5) who take Cipro
Fever
  • 11.49% for females aged 50 (±5) who take Cefixime
  • 7.66% for females aged 50 (±5) who take Cipro
Furuncle
  • 5.75% for females aged 50 (±5) who take Cefixime
Gait disturbance
  • 6.13% for females aged 50 (±5) who take Cipro
Gastroenteritis viral
  • 10.34% for females aged 50 (±5) who take Cefixime
Gastroesophageal reflux disease
  • 5.75% for females aged 50 (±5) who take Cefixime
Haemoglobin decreased
  • 9.2% for females aged 50 (±5) who take Cefixime
Headache
  • 7.66% for females aged 50 (±5) who take Cipro
Hepatic artery thrombosis
  • 5.75% for females aged 50 (±5) who take Cefixime
Hepatic encephalopathy
  • 6.9% for females aged 50 (±5) who take Cefixime
Hepatic necrosis
  • 5.75% for females aged 50 (±5) who take Cefixime
Hepatitis fulminant
  • 5.75% for females aged 50 (±5) who take Cefixime
Hypotension
  • 9.2% for females aged 50 (±5) who take Cefixime
Joint pain
  • 8.97% for females aged 50 (±5) who take Cipro
Liver transplant
  • 5.75% for females aged 50 (±5) who take Cefixime
Malaise
  • 6.56% for females aged 50 (±5) who take Cipro
Melaena
  • 5.75% for females aged 50 (±5) who take Cefixime
Migraine
  • 5.03% for females aged 50 (±5) who take Cipro
Nausea
  • 9.19% for females aged 50 (±5) who take Cipro
Nausea and vomiting
  • 7.0% for females aged 50 (±5) who take Cipro
Neck pain
  • 5.75% for females aged 50 (±5) who take Cefixime
Neuropathy peripheral
  • 5.75% for females aged 50 (±5) who take Cefixime
Otitis externa
  • 5.75% for females aged 50 (±5) who take Cefixime
Pain
  • 7.66% for females aged 50 (±5) who take Cipro
Pain in extremity
  • 6.13% for females aged 50 (±5) who take Cipro
Peritoneal haemorrhage
  • 5.75% for females aged 50 (±5) who take Cefixime
Presbyopia
  • 5.75% for females aged 50 (±5) who take Cefixime
Rashes
  • 10.34% for females aged 50 (±5) who take Cefixime
  • 8.53% for females aged 50 (±5) who take Cipro
Restless leg syndrome
  • 5.75% for females aged 50 (±5) who take Cefixime
Schizoaffective disorder
  • 5.75% for females aged 50 (±5) who take Cefixime
Stress and anxiety
  • 5.91% for females aged 50 (±5) who take Cipro
Tendonitis
  • 5.75% for females aged 50 (±5) who take Cefixime
Thrombocytopenia
  • 5.75% for females aged 50 (±5) who take Cefixime
Type 2 diabetes
  • 5.75% for females aged 50 (±5) who take Cefixime
Vaginal infection
  • 5.75% for females aged 50 (±5) who take Cefixime
Weakness
  • 7.66% for females aged 50 (±5) who take Cipro
Weight increased
  • 5.75% for females aged 50 (±5) who take Cefixime

Most common co-existing conditions:

Abdominal discomfort
  • 8.05% for females aged 50 (±5) who take Cefixime
Back pain
  • 10.34% for females aged 50 (±5) who take Cefixime
Depression
  • 10.34% for females aged 50 (±5) who take Cefixime
Diuretic therapy
  • 10.34% for females aged 50 (±5) who take Cefixime
Fever
  • 8.05% for females aged 50 (±5) who take Cefixime
Headache
  • 12.64% for females aged 50 (±5) who take Cefixime
High blood cholesterol
  • 8.05% for females aged 50 (±5) who take Cefixime
High blood pressure
  • 10.34% for females aged 50 (±5) who take Cefixime
Hiv infection
  • 6.9% for females aged 50 (±5) who take Cefixime
Hyperlipidaemia
  • 8.05% for females aged 50 (±5) who take Cefixime
Hypersensitivity
  • 10.34% for females aged 50 (±5) who take Cefixime
Joint pain
  • 10.34% for females aged 50 (±5) who take Cefixime
Pain
  • 7.22% for females aged 50 (±5) who take Cipro
Stress and anxiety
  • 10.34% for females aged 50 (±5) who take Cefixime
Tuberculosis
  • 5.75% for females aged 50 (±5) who take Cefixime
Uveitis
  • 10.34% for females aged 50 (±5) who take Cefixime
Vitamin supplementation
  • 10.34% for females aged 50 (±5) who take Cefixime
back to top

Males aged 50 to 59 :

398 related reports were analyzed:

Most common symptoms:

Agranulocytosis
  • 14.81% for males aged 50 (±5) who take Cefixime
Anaemia
  • 5.52% for males aged 50 (±5) who take Cipro
Back pain
  • 9.26% for males aged 50 (±5) who take Cefixime
Eosinophilia
  • 12.96% for males aged 50 (±5) who take Cefixime
Fever
  • 11.11% for males aged 50 (±5) who take Cefixime
  • 5.23% for males aged 50 (±5) who take Cipro
Itching
  • 14.81% for males aged 50 (±5) who take Cefixime
Rashes
  • 5.52% for males aged 50 (±5) who take Cipro
Stress and anxiety
  • 5.81% for males aged 50 (±5) who take Cipro
Weakness
  • 9.26% for males aged 50 (±5) who take Cefixime
  • 6.1% for males aged 50 (±5) who take Cipro

Most common co-existing conditions:

Fever
  • 11.11% for males aged 50 (±5) who take Cefixime
High blood pressure
  • 7.27% for males aged 50 (±5) who take Cipro
Pain
  • 7.27% for males aged 50 (±5) who take Cipro
Type 2 diabetes
  • 14.81% for males aged 50 (±5) who take Cefixime
back to top

Do you take Cefixime and Cipro:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Cefixime

Cefixime has active ingredients of cefixime. (latest outcomes from Cefixime 917 users)

Cipro

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. (latest outcomes from Cipro 24,540 users)

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.